Business Context and Reporting Period
This unaudited Form 10-Q was filed by Brooks Automation, Inc. (now associated with Azenta, Inc.) for the three months ended December 31, 2015, the first quarter of fiscal 2016. The company operated through Brooks Product Solutions, Brooks Global Services, and Brooks Life Science Systems, serving semiconductor capital equipment and life-science sample-management markets.
Key Financial Metrics
| Metric | Q1 FY2016 | Q1 FY2015 | Change |
|---|---|---|---|
| Total revenue | $120.0 million | $122.7 million | Down $2.8 million |
| Gross profit | $40.6 million | $39.1 million | Up $1.5 million |
| Gross margin | 33.8% | 31.8% | Up 200 bps |
| Operating loss | $8.3 million | $6.5 million | Higher loss by $1.8 million |
| Net loss | $4.6 million | $2.7 million | Higher loss by $1.9 million |
| Diluted loss per share | $0.07 | $0.04 | Higher loss per share |
| Cash flow from operations | $(12.4) million | $3.0 million | Decrease of $15.4 million |
Product revenue was $89.2 million, down from $99.7 million, while services revenue increased to $30.8 million from $23.0 million. The effective income tax benefit was $3.4 million, compared with $3.1 million in the prior-year quarter. The company declared a $0.10 per-share dividend for the quarter.
At December 31, 2015, cash and cash equivalents were $55.6 million and marketable securities were $9.7 million, for total cash and investments of $65.2 million, compared with $214.0 million at September 30, 2015. The filing reports no significant conventional debt balance; liabilities totaled $128.8 million, including $3.0 million of long-term tax reserves and other long-term liabilities.
Material Changes Versus the Prior Comparable Period
- Revenue declined 2.3%, primarily because Brooks Product Solutions revenue fell $6.3 million and foreign-exchange movements reduced revenue by approximately $2.0 million.
- Brooks Life Science Systems revenue rose $4.2 million to $20.9 million, including $6.5 million contributed by the newly acquired BioStorage business.
- Gross margin improved to 33.8%, driven by stronger margins in Product Solutions and Life Science Systems. Global Services margin declined from 36.5% to 33.6%.
- Operating expenses increased, including selling, general and administrative expense of $34.1 million versus $29.4 million. BioStorage transaction costs accounted for $2.9 million of the current-quarter expense.
- Restructuring charges declined to $1.5 million from $2.7 million, reflecting workforce reductions, facility-cost reductions, and integration activities.
- The company acquired BioStorage Technologies on November 30, 2015 for $125.5 million net of cash acquired. The acquisition added $79.9 million of goodwill and $41.5 million of intangible assets on a preliminary basis.
- Cash declined by $25.2 million, mainly because of the BioStorage acquisition, operating cash use, dividends, and capital expenditures. Marketable securities were substantially liquidated to fund the transaction.
Guidance, Outlook, Risks, and Unusual Items
- Management stated that it expects stronger U.S. business performance during the remainder of fiscal 2016 and expects to be profitable in the United States for the full fiscal year. Failure to meet that expectation could require an additional valuation allowance against U.S. deferred tax assets.
- Management expects continued growth in Life Science Systems through internally developed products, including Twin-bank and Biostore III systems, and through acquisitions.
- The semiconductor capital-equipment market is cyclical and caused significant quarter-to-quarter volatility. Product Solutions revenue in the current quarter was $27.2 million below the fourth quarter of fiscal 2015.
- BioStorage contributed $6.5 million of revenue but had a 22.9% margin and a $0.6 million net loss in the acquisition period. Integration and retention costs remain relevant.
- Royalty income increased to $1.9 million from $1.5 million but is expected to decline as certain licensed patents expire within the following 12 months.
- Foreign-exchange losses were $0.5 million, and management estimated that a hypothetical 10% currency movement would change net loss by approximately $0.4 million.
- The company reported $3.5 million of outstanding letters of credit, primarily supporting customer advances and performance obligations. None had been called.
- Legal proceedings arise in the ordinary course of business; management did not believe any known matter would have a material adverse effect, but acknowledged that outcomes are inherently uncertain.
- The company stated that it had adequate resources for planned working capital and capital expenditures for the next twelve months, while noting that cyclical markets could make longer-term liquidity needs difficult to predict.
- On February 3, 2016, the board declared a $0.10 per-share dividend payable March 24, 2016. Future dividends remain discretionary and could be reduced, delayed, or canceled during a severe downturn.
Most Important Facts to Verify
- Confirm the corporate-name transition from Brooks Automation, Inc. to Azenta, Inc. and the applicability of this 2015 filing to the requested company.
- Verify the preliminary purchase-price allocation, goodwill, intangible assets, and integration costs associated with BioStorage.
- Assess whether the expected U.S. fiscal-year profitability was achieved and whether deferred tax asset valuation allowances subsequently changed.
- Monitor cash generation after the $125.5 million acquisition and the substantial reduction in marketable securities.
- Evaluate semiconductor-market demand, Product Solutions volatility, and the sustainability of improved gross margins.
- Review the effect of patent expirations on royalty income and the potential impact of foreign-exchange movements.
- Check subsequent filings for litigation developments, contingent consideration, acquisition adjustments, restructuring obligations, and dividend policy changes.